Dr. Pramod Kumar Julka is one of India’s most distinguished and pioneering oncologists, with over 47 years of excellence in cancer care. He is widely recognized for his groundbreaking work in medical oncology, stem cell transplantation, and multidisciplinary cancer treatment, making him a leading authority in modern cancer management.
Dr. Pramod Kumar Julka has more than 47 years of experience in oncology. He currently serves as Vice Chairman – Oncology at Max Healthcare, New Delhi. He has held several prestigious academic and leadership positions, including Dean (Academics) and Professor in the Department of Radiotherapy & Oncology at AIIMS, New Delhi. He has also served as President of the Association of Radiation Oncologists of India (Northern Chapter), Chairperson of the Indian College of Radiation Oncology, and has spent several years as a senior academic and clinical oncologist at AIIMS.
Professional Memberships
Emeritus Member – American Society of Clinical Oncology (ASCO)
Member – Society of Cancer Research
Member – National Advisory Committee, Global Cancer Summit 2015
Member – Indian Council of Medical Research (ICMR) Task Force
WHO Fellowship – MD Anderson & Long Beach Memorial Cancer Centre (1995)
Limca Book of Records (1998) – First PBSC Transplant in Metastatic Breast Cancer
IMA Award for Medical Education & Research (2000–2001)
OISCA Foundation (UN) Award (2001)
Leading Scientist of the World Award (2005)
NDB Oration Award (2005)
Dr. G.D. Pandey Oration Award (2006)
IMA Award for Clinical Oncology (2006)
Best Orator Award (2009)
Lifetime Achievement Award – AROI (2013)
Padma Shri Award – Government of India (2013)
More than 47 years of oncology experience
Pioneer in stem cell transplantation and modern cancer management
Extensive expertise across multiple cancer specialties
Former senior academic leader at AIIMS, New Delhi
Published over 250 research papers
Active contributor to cancer research and clinical trials
Recipient of Padma Shri and multiple national and international honors
Strong experience in multidisciplinary cancer care and advanced oncology treatments